Gastrectomy versus stomach left in situ with Roux-en-Y reconstruction for the treatment of gastroparesis

  • Joshua P. LandreneauEmail author
  • Andrew T. Strong
  • Kevin El-Hayek
  • Matthew D. Kroh
  • John H. Rodriguez
2019 SAGES Oral



Gastroparesis is a debilitating functional disorder of the stomach marked by delayed gastric emptying in the absence of mechanical obstruction. Patients with severe, refractory symptoms may ultimately be managed with Roux-en-Y reconstruction; however, it is unclear whether the stomach should be left in situ, similar to a conventional gastric bypass, or resected as in gastrectomy.


All patients undergoing Roux-en-Y for the treatment of gastroparesis (GP) at our institution from September 2010 through March 2018 were retrospectively reviewed. Patients with prior gastric resection or whose primary operative indication was not gastroparesis were excluded from analysis.


Twenty-six patients underwent Roux-en-Y with stomach left in situ (RY-SIS) and twenty-seven patients underwent gastrectomy with Roux-en-Y reconstruction during the study period. The mean age was 49.7 years in the RY-SIS cohort and 48.5 years in the gastrectomy cohort. Etiology of GP was similar between the two cohorts. Patients undergoing gastrectomy were more likely to have previous interventions for GP (63.0% vs. 26.9%). RY-SIS was associated with a shorter operative time (155 vs. 223 min), less blood loss (24 vs. 130 mL), and shorter length of stay (4.0 vs. 7.2 days). Twelve patients (44.4%) had complications within 30 days following gastrectomy compared to two patients (7.7%) following RY-SIS (p = 0.001). Patients in the RY-SIS cohort were more likely to require further subsequent surgical intervention for GP (23.1% vs. 3.7%, p = 0.04). At last follow-up, there were no differences in reported GP symptoms or symptom scoring.


Gastrectomy was associated with greater perioperative morbidity compared to leaving the stomach in situ. Symptomatic improvement at intermediate follow-up was equivalent following either procedure. However, patients undergoing RY-SIS were more likely to require subsequent surgical intervention, suggesting that gastrectomy may be a more definitive operation for the management of medically refractory gastroparesis.


Gastroparesis Gastrectomy Roux-en-Y 


Compliance with ethical standards


Matthew D. Kroh has no conflict of interest relevant to this publication. Outside of the scope of this work, he serves as a consultant for Levita Magnetics and Medtronic. He has received research funding from Cook. John H. Rodriguez has no conflict of interest relevant to this publication. Outside of the scope of this publication, he has received research funding from Pacira Pharmaceuticals and Intuitive Surgical. Joshua P. Landreneau, Andrew Strong, Kevin El-Hayek have no conflict of interest or financial ties to disclose.


  1. 1.
    Hasler WL (2007) Gastroparesis: symptoms, evaluation, and treatment. Gastroenterol Clin N Am 36:619–647CrossRefGoogle Scholar
  2. 2.
    Shen S, Xu J, Lamm V, Vachaparambil CT, Chen H, Cai Q (2019) Diabetic gastroparesis and nondiabetic gastroparesis. Gastrointest Endosc Clin N Am 29:15–25. CrossRefGoogle Scholar
  3. 3.
    Homko CJ, Duffy F, Friedenberg FK, Boden G, Parkman HP (2015) Effect of dietary fat and food consistency on gastroparesis symptoms in patients with gastroparesis. Neurogastroenterol Motil 27:501–508. CrossRefGoogle Scholar
  4. 4.
    Myint AS, Rieders B, Tashkandi M, Borum ML, Koh JM, Stephen S, Doman DB (2018) Current and emerging therapeutic options for gastroparesis. Gastroenterol Hepatol 14:639–645Google Scholar
  5. 5.
    Shada AL, Dunst CM, Pescarus R, Speer EA, Cassera M, Reavis KM, Swanstrom LL (2016) Laparoscopic pyloroplasty is a safe and effective first-line surgical therapy for refractory gastroparesis. Surg Endosc 30:1326–1332. CrossRefGoogle Scholar
  6. 6.
    Lal N, Livemore S, Dunne D, Khan I (2015) Gastric electrical stimulation with the enterra system: a systematic review. Gastroenterol Res Pract 2015:9. CrossRefGoogle Scholar
  7. 7.
    Mancini SA, Angelo JL, Peckler Z, Philp FH, Farah KF (2015) Pyloroplasty for refractory gastroparesis. Am Surg 81:738–746Google Scholar
  8. 8.
    Gonzalez JM, Benezech A, Vitton V, Barthet M (2017) G-POEM with antro-pyloromyotomy for the treatment of refractory gastroparesis: mid-term follow-up and factors predicting outcome. Aliment Pharmacol Ther 46:364–370. CrossRefGoogle Scholar
  9. 9.
    Rodriguez J, Strong AT, Haskins IN, Landreneau JP, Allemang MT, El-Hayek K, Villamere J, Tu C, Cline MS, Kroh M, Ponsky JL (2018) Per-oral pyloromyotomy (POP) for medically refractory gastroparesis: short term results from the first 100 patients at a high volume center. Ann Surg 268:421–430. CrossRefGoogle Scholar
  10. 10.
    Wakamatsu K, Perez Quirante F, Montorfano L, Lo Menzo E, Seto Y, Rosenthal RJ (2018) Laparoscopic treatment of gastroparesis: a single center experience. Surg Obes Relat Dis 14:200–205CrossRefGoogle Scholar
  11. 11.
    McCallum RW, Polepalle SC, Schirmer B (1991) Completion gastrectomy for refractory gastroparesis following surgery for peptic ulcer disease. Long-term follow-up with subjective and objective parameters. Dig Dis Sci 36:1556–1561CrossRefGoogle Scholar
  12. 12.
    Abell TL, Camilleri M, Donohoe K, Hasler WL, Lin HC, Maurer AH, McCallum RW, Nowak T, Nusynowitz ML, Parkman HP, Shreve P, Szarka LA, Snape WJ, Ziessman HA, American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine (2008) Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. Am J Gastroenterol 103:753–763. CrossRefGoogle Scholar
  13. 13.
    Revicki DA, Rentz AM, Dubois D, Kahrilas P, Stanghellini V, Talley NJ, Tack J (2004) Gastroparesis Cardinal Symptom Index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms. Qual Life Res 13:833–844. CrossRefGoogle Scholar
  14. 14.
    Strong AT, Landreneau JP, Cline M, Kroh MD, Rodriguez JH, Ponsky JL, El-Hayek K (2019) Per-oral pyloromyotomy (POP) for medically refractory post-surgical gastroparesis. J Gastrointest Surg. Google Scholar
  15. 15.
    Landreneau JP, Strong AT, El-Hayek K, Tu C, Villamere J, Ponsky JL, Kroh MD, Rodriguez JH (2019) Laparoscopic pyloroplasty versus endoscopic per-oral pyloromyotomy for the treatment of gastroparesis. Surg Endosc 33:773–781. CrossRefGoogle Scholar
  16. 16.
    Watkins PJ, Buxton-Thomas MS, Howard ER (2003) Long-term outcome after gastrectomy for intractable diabetic gastroparesis. Diabet Med 20:58–63CrossRefGoogle Scholar
  17. 17.
    Papasavas PK, Ng JS, Stone AM, Ajayi OA, Muddasani KP, Tishler DS (2014) Gastric bypass surgery as treatment of recalcitrant gastroparesis. Surg Obes Relat Dis 10:795–799. CrossRefGoogle Scholar
  18. 18.
    Speicher JE, Thirlby RC, Burggraaf J, Kelly C, Levasseur S (2009) Results of completion gastrectomies in 44 patients with postsurgical gastric atony. J Gastrointest Surg 13:874–880. CrossRefGoogle Scholar
  19. 19.
    Bhayani NH, Sharata AM, Dunst CM, Kurian AA, Reavis KM, Swanstrom LL (2015) End of the road for a dysfunctional end organ: laparoscopic gastrectomy for refractory gastroparesis. J Gastrointest Surg 19:411–417. CrossRefGoogle Scholar
  20. 20.
    Sun Z, Rodriguez J, McMichael J, Chand B, Nash D, Brethauer S, Schauer P, El-Hayek K, Kroh M (2015) Surgical treatment of medically refractory gastroparesis in the morbidly obese. Surg Endosc 29:2683–2689. CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of General SurgeryCleveland ClinicClevelandUSA
  2. 2.Cleveland Clinic Lerner College of Medicine of Case Western Reserve UniversityClevelandUSA
  3. 3.Digestive Disease InstituteCleveland Clinic Abu DhabiAbu DhabiUnited Arab Emirates

Personalised recommendations